Literature DB >> 12900782

Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah's witness.

T Zenz1, H Döhner, D Bunjes.   

Abstract

With an estimated 6000000 Jehovah's witnesses worldwide, haematologists may encounter patients who decline blood transfusions as a matter of personal belief. Here, we describe the first case of a transfusion-free allogeneic stem cell transplant (SCT) in a Jehovah's witness with CML. The patient underwent HLA-identical peripheral blood SCT after reduced-intensity conditioning with total body irradiation and fludarabine. Conditioning and the period after transplantation were uneventful, complete donor chimerism was achieved and the patient continues to be in molecular remission without significant chronic graft-versus-host disease. When treating Jehovah's witnesses with diseases that may be cured by allogeneic SCT, this approach should be kept in mind.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900782     DOI: 10.1038/sj.bmt.1704121

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  2 in total

1.  Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients.

Authors:  P Mazza; G Palazzo; C Minoia; B Amurri; G Pisapia
Journal:  Bone Marrow Transplant       Date:  2016-03-07       Impact factor: 5.483

2.  Induction with azacytidine followed by allogeneic hematopoietic stem cell transplantation in a Jehovah's Witness with acute monocytic leukemia.

Authors:  Hege Garelius; Sofia Grund; Dick Stockelberg
Journal:  Clin Case Rep       Date:  2015-02-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.